We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal judge in Newark, N.J., gave preliminary approval for a $36 million
nationwide settlement in an antitrust case involving the antidepressant Remeron.
LAM Pharmaceutical, a biomedical company focused on the development and commercialization
of novel wound healing and transdermal drug delivery systems, has received a
second order for IPM Wound Gel from Sinopharm Group, a subsidiary of one of
China's largest pharmaceutical companies.
Alexion Pharmaceuticals in Cheshire, Conn., has completed
the sale of $150 million principal amount of convertible senior notes due 2012
to unnamed institutional buyers.
Pfizer's top executives have denied reports that the company's fourth quarter
earnings report contained references to additional clinical data that could
be used to argue that its Cox-2 inhibitor Celebrex poses heart risks.
German drugmaker Boehringer Ingelheim doesn't anticipate that a recent FDA health
advisory for its HIV drug Viramune will have a major impact on the drug's sales
or distribution.
The safety of antistroke drug Plavix -- one of the world's
top-selling brands -- was called into question recently following the release
of new clinical research that shows the drug might cause a high rate of recurrent
ulcers.
The FDA's inability to evolve and keep pace with the rapidly advancing pharmaceutical
industry has left it with a wide array of problems, particularly on the drug
safety front, asserts Eve Slater, former assistant secretary for health at HHS.
Genetronics Biomedical, a late stage developer of oncology and other therapies
using electroporation to deliver drugs and nucleic acids, has announced the
acquisition of Oslo-based Inovio AS, a leader in patented gene delivery technology
for the most efficient, nonviral method for gene transfer to skeletal muscles.
Genaissance Pharmaceuticals, a leading developer and user of genetic information
to help guide medical therapy, expanded its ability to provide genetic tests
for critical variants of key cardiac ion channel proteins involved in drug-induced
cardiac arrhythmias.